Implications of dispensing self-administered hormonal contraceptives in a 1-year supply: a California case study
| Autor: | Sara B. McMenamin, Erin Shigekawa, Garen Corbett, Nadia Tabatabaeepour, Shana Alex Charles |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Prescription Drugs
Time Factors Research methodology Legislation Self Administration Administration Cutaneous California Drug Costs Contraceptives Oral Hormonal 03 medical and health sciences 0302 clinical medicine Pregnancy Health care Health insurance Contraceptive Agents Female Medicine Humans Operations management 030212 general & internal medicine 030219 obstetrics & reproductive medicine business.industry Obstetrics and Gynecology Contraceptive Devices Female Pregnancy Unplanned Legislation Drug Vaginal ring Administration Intravaginal Reproductive Medicine Family planning Pill Insurance Health Reimbursement Female business Developed country Demography |
| Zdroj: | Contraception. 95(5) |
| ISSN: | 1879-0518 |
| Popis: | On September 23, 2016, California became the sixth state to pass legislation requiring health plans and insurers to cover a 12-month supply of FDA-approved self-administered hormonal contraceptives such as contraceptive pills, patches and vaginal rings. This legislation is estimated to result in 38% of current contraceptive pill, patch, and ring users receiving a 12-month supply dispensed at one time. This shift in dispensing patterns was estimated to result in a reduction of 15,000 unintended pregnancies; 2000 fewer miscarriages; and 7000 fewer abortions in California decreasing total net health care expenditures by 0.03%. With similar legislation introduced in 17 states, the findings from this study are important for consideration outside of California. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect